Vivoryon Therapeutics NV VVY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €0.47
- Day Range
- €0.44–0.47
- 52-Week Range
- €0.41–19.56
- Bid/Ask
- €0.45 / €0.48
- Market Cap
- €11.76 Mil
- Volume/Avg
- 99,759 / 648,383
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 17
- Website
- https://www.vivoryon.com
Comparables
Valuation
|
Metric
|
VVY
|
MRUS
|
IMTX
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.29 | 6.57 | 3.49 |
Price/Sales | — | 47.52 | 14.14 |
Price/Cash Flow | — | — | — |
Price/Earnings
VVY
MRUS
IMTX
Financial Strength
|
Metric
|
VVY
|
MRUS
|
IMTX
|
|---|---|---|---|
Quick Ratio | 18.38 | 5.19 | 2.76 |
Current Ratio | 19.45 | 5.34 | 2.87 |
Interest Coverage | −104.42 | — | −132.38 |
Quick Ratio
VVY
MRUS
IMTX
Profitability
|
Metric
|
VVY
|
MRUS
|
IMTX
|
|---|---|---|---|
Return on Assets (Normalized) | −61.97% | −30.87% | −15.61% |
Return on Equity (Normalized) | −72.07% | −42.51% | −30.30% |
Return on Invested Capital (Normalized) | −68.80% | −44.25% | −33.80% |
Return on Assets
VVY
MRUS
IMTX
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Yzbhznsgfv | Wlsq | $550.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Dlyxstkb | Ygrrjy | $101.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Lwjffdl | Dzvdfy | $98.1 Bil | |
MRNA
| Moderna Inc | Zqhxwbl | Jgzmc | $39.1 Bil | |
ARGX
| argenx SE ADR | Tbrywnwh | Vbqv | $21.7 Bil | |
BNTX
| BioNTech SE ADR | Kmnjlncwn | Klknm | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Fbgtbphf | Bncns | $18.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rfyppykx | Flqpcb | $17.1 Bil | |
RPRX
| Royalty Pharma PLC Class A | Pdrlqsvh | Pypqk | $12.5 Bil | |
INCY
| Incyte Corp | Kwxsxfdjl | Hfjrdsh | $11.9 Bil |